Literature DB >> 1494767

Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up.

C Agustí1, A Xaubet, J Roca, A G Agustí, R Rodriguez-Roisin.   

Abstract

BACKGROUND: Interstitial pulmonary fibrosis is a disease with a highly variable clinical course. To ascertain if an inadequate selection of patients might explain part of this variability, two different groups of patients with interstitial pulmonary fibrosis, those with the "lone" form of the disease (LIPF) and those with associated collagen vascular disorders (AIPF), were studied separately.
METHODS: Twenty consecutive patients (nine with LIPF and 11 with AIPF) were included. Their clinical and radiographic findings and results of pulmonary function tests, gallium-67 lung scanning, and cellular analysis of bronchoalveolar lavage fluid were compared at diagnosis. Moreover, the evolution of LIPF and AIPF was contrasted after a follow up of two years, both groups having received a similar treatment regimen of corticosteroids.
RESULTS: At enrollment, patients with LIPF and AIPF were of similar age, and had similar symptoms and derangement of lung function, but patients with LIPF presented with finger clubbing, more obvious radiographic abnormalities, and a greater percentage of eosinophils in bronchoalveolar lavage fluid. Two years later, patients with LIPF had significantly decreased FVC, FEV1, TLC, TLCO, and PaO2. By contrast, lung function remained unaltered in patients with AIPF. Similarly, when the percentage change from entry to the study was compared, patients with LIPF showed a significant decrease in FVC, FEV1, and PaO2.
CONCLUSIONS: Unlike the patients with AIPF, those with LIPF showed a deterioration in lung function and developed further restrictive impairment and poorer gas exchange. This has implications in their clinical management.

Entities:  

Mesh:

Year:  1992        PMID: 1494767      PMCID: PMC1021096          DOI: 10.1136/thx.47.12.1035

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  38 in total

1.  SYSTEMIC ARTERIAL PATTERNS IN THE LUNG AND CLUBBING OF THE FINGERS.

Authors:  M TURNER-WARWICK
Journal:  Thorax       Date:  1963-09       Impact factor: 9.139

2.  Spirometric reference values from a Mediterranean population.

Authors:  J Roca; J Sanchis; A Agusti-Vidal; F Segarra; D Navajas; R Rodriguez-Roisin; P Casan; S Sans
Journal:  Bull Eur Physiopathol Respir       Date:  1986 May-Jun

3.  Natural history and treated course of usual and desquamative interstitial pneumonia.

Authors:  C B Carrington; E A Gaensler; R E Coutu; M X FitzGerald; R G Gupta
Journal:  N Engl J Med       Date:  1978-04-13       Impact factor: 91.245

4.  The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function.

Authors:  R Hällgren; L Bjermer; R Lundgren; P Venge
Journal:  Am Rev Respir Dis       Date:  1989-02

Review 5.  Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment.

Authors:  R J Panos; R L Mortenson; S A Niccoli; T E King
Journal:  Am J Med       Date:  1990-04       Impact factor: 4.965

6.  Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature.

Authors:  M I Schwarz; R A Matthay; S A Sahn; R E Stanford; B L Marmorstein; D J Scheinhorn
Journal:  Medicine (Baltimore)       Date:  1976-01       Impact factor: 1.889

7.  Prognostic role of eosinophils in pulmonary fibrosis.

Authors:  M W Peterson; M Monick; G W Hunninghake
Journal:  Chest       Date:  1987-07       Impact factor: 9.410

8.  Patients with collagen vascular disease and dyspnea. The value of gallium scanning and bronchoalveolar lavage in predicting response to steroid therapy and clinical outcome.

Authors:  N B Greene; A M Solinger; R P Baughman
Journal:  Chest       Date:  1987-05       Impact factor: 9.410

9.  Lung biopsy in rheumatoid arthritis.

Authors:  S A Yousem; T V Colby; C B Carrington
Journal:  Am Rev Respir Dis       Date:  1985-05

10.  Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population.

Authors:  J Roca; R Rodriguez-Roisin; E Cobo; F Burgos; J Perez; J L Clausen
Journal:  Am Rev Respir Dis       Date:  1990-04
View more
  9 in total

1.  Lower-lobe shrinkage relative to total lung volume in collagen vascular diseases.

Authors:  M Watanabe; T Igishi; N Burioka; J Kurai; Y Fukuoka; K Kato; A Yamasaki; Y Hasegawa; R Okazaki; E Shimizu
Journal:  Radiol Med       Date:  2010-06-23       Impact factor: 3.469

2.  Clinical, laboratory and radiological findings in pulmonary fibrosis with and without connective tissue disease.

Authors:  E Renzoni; P Rottoli; G Coviello; M G Perari; M Galeazzi; M Vagliasindi
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

Review 3.  Oxidants/antioxidants in idiopathic pulmonary fibrosis.

Authors:  W MacNee; I Rahman
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

Review 4.  Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.

Authors:  Kundan Iqbal; Clive Kelly
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

5.  A possible role of galectin-9 in the pulmonary fibrosis of patients with interstitial pneumonia.

Authors:  Nobuhiro Matsumoto; Shigeki Katoh; Shigehisa Yanagi; Yasuji Arimura; Masatoshi Tokojima; Masaki Ueno; Mitsuomi Hirashima; Masamitsu Nakazato
Journal:  Lung       Date:  2013-01-16       Impact factor: 2.584

Review 6.  Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.

Authors:  Beth Wallace; Dharshan Vummidi; Dinesh Khanna
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

7.  Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis.

Authors:  C Agusti; A Xaubet; P Luburich; M C Ayuso; J Roca; R Rodriguez-Roisin
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

8.  Nonspecific interstitial pneumonia: clinical associations and outcomes.

Authors:  WenBin Xu; Yi Xiao; HongRui Liu; MingWei Qin; WenJie Zheng; JuHong Shi
Journal:  BMC Pulm Med       Date:  2014-11-07       Impact factor: 3.317

9.  Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosis.

Authors:  Edwin Roger Parra; Aline Domingos Pinto Ruppert; Vera Luiza Capelozzi
Journal:  Clinics (Sao Paulo)       Date:  2014-01       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.